Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study
Authors not listed
Istituto Oncologico Veneto IRCCS · 2019
Abstract
The purpose of this study is to evaluate the safety and efficacy of Cabozantinib in the treatment of patients with renal cell carcinoma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2019). Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study. <em>Istituto Oncologico Veneto IRCCS</em>. https://clinicaltrials.gov/study/NCT04416646
Vancouver
Anonymous. Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study. Istituto Oncologico Veneto IRCCS. 2019.
BibTeX
@misc{anon2019Caboza,
title = {Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study},
author = {Anonymous},
journal = {Istituto Oncologico Veneto IRCCS},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Longeveron Inc. 2014
Open access · US-GOV
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
Palomar Medical Technologies, Inc. 2007
Open access · US-GOV
Safety and Efficacy Evaluation of Fractional Erbium Treatment
Gustave Roussy, Cancer Campus, Grand Paris 2025
Open access · US-GOV
Cabozantinib and Nivolumab Among Older Patients With Renal-cell Carcinoma, a Prospective Cohort With Geriatric, Pharmacologic and Patient-reported-outcome Evaluation
Galaxia Empírica 2023
Open access · US-GOV
Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
The First Affiliated Hospital with Nanjing Medical University 2020
Open access · US-GOV
Efficacy and Safety of Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Regeneron Pharmaceuticals 2013
Open access · US-GOV